Global Traumatic Brain Injuries Assessment and Management Devices Market Size study, by Device (Imaging Devices, Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Monitoring Devices, Others) by Technique (pBrO2, ICP Monitoring), by End

Global Traumatic Brain Injuries Assessment and Management Devices Market Size study, by Device (Imaging Devices, Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Monitoring Devices, Others) by Technique (pBrO2, ICP Monitoring), by End Use (Hospitals, Diagnostic Centers, Others) and Regional Forecasts 2022-2028

Global Traumatic Brain Injuries Assessment and Management Devices Market is valued approximately USD 2.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.50% over the forecast period 2022-2028. TBIs are commonly caused by sports injuries, falls, gunshot wounds, domestic abuse, and car accidents. According to the Center for Disease Control, TBI is responsible for 2.8 million accidents and emergency room visits in the United States each year. Furthermore, according to Stanford Children's Health, over 3.5 million sports-related injuries are recorded yearly among children in the United States, with TBIs accounting for around 21% of all. Thus, rising TBI instances from sports injuries, car accidents, and assaults are expected to drive market expansion throughout the forecast period. Rising desire for less invasive neuro treatments due to reduced pain and infection risk, as well as faster recovery, is projected to drive demand for TBI evaluation and management devices. Furthermore, a rising number of initiatives and programmes relating to brain injuries being undertaken by governments throughout the world are likely to fuel market expansion. For example, the Brain Injury Association of America (BIAA) sponsors a nationwide public awareness campaign in March each year to underscore the need of addressing the effects of brain injuries as a traumatic brain injury project. TBIs in active-duty military members are frequently caused by gunshots or explosive blasts. According to the Defense and Veterans Brain Injury Center (DVBIC), between 2000 and late 2019, around 414,000 TBIs were documented among U.S. service members. Also, according to the Brain Injury Association Waterloo-Wellington, over 11,000 people die in Canada each year as a result of TBIs, and over 6,000 become permanently handicapped as a result of TBIs. As a result, the high incidence rate of TBIs is expected to promote market growth throughout the projection period. However, the high cost of therapy may stymie market expansion between 2022 and 2028.

The key regions considered for the Global Traumatic Brain Injuries Assessment and Management Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America has risen to the top of the market, due to the existence of well-established healthcare facilities in the region, increased government activities, brain injury awareness campaigns, and a higher prevalence of TBIs across the continent. From 2022 to 2028, the Asia Pacific area is predicted to develop at the fastest CAGR. This is due to reasons such as an ageing population, an increase in the number of persons suffering from TBIs, an increase in the frequency of vehicle accidents, and increased violence.

Major market player included in this report are:
Integra Lifesciences
BioDirection, Inc.
Nihon Kohden Corp.
Compumedics Ltd.
InfraScan, Inc.
Oculogica
Raumedic AG
BrainScope Corporation Inc
Elekta AB
Integralife
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Device:
Imaging Devices
Magnetic Resonance Imaging (MRI) Devices
X-Ray
Computed Tomography
Monitoring Devices
Others
By Technique:
pBrO2
ICP Monitoring
By End Use:
Hospitals
Diagnostic Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Traumatic Brain Injuries Assessment and Management Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Integra Lifesciences
BioDirection, Inc.
Nihon Kohden Corp.
Compumedics Ltd.
InfraScan, Inc.
Oculogica
Raumedic AG
BrainScope Corporation Inc
Elekta AB
Integralife

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.